Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Autoimmune Disorders

Free Subscription 19.01.2026 10 Diabetes Res Clin Pract 2 J Neurol 1 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Diabetes Res Clin Pract

1. WAGNER J, Bermudez-Millan A, Feinn RS
   Health-related social needs and self-Reported health among adults with type 1 diabetes in the 2022 Behavioral Risk Factor Surveillance System.
   Diabetes Res Clin Pract. 2026;231:113077.
   PubMed         Abstract available
   
   
2. LAINE MK, Haapala M, Uusi-Rauva K, Aakko J, et al
   Disease management, outcomes, and healthcare resource utilization in real-life clinical practice of diabetes and diabetic kidney disease in Finland.
   Diabetes Res Clin Pract. 2026;231:113067.
   PubMed         Abstract available
   
   
3. OZAIRI EA, Taghadom E, Irshad M, Yousef AA, et al
   Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m(2), and chronic kidney disease - A randomised, controlled pilot study.
   Diabetes Res Clin Pract. 2026;231:113066.
   PubMed         Abstract available
   
   
4. WAGNER R, Fuchtenbusch M, Hummel M, Miszon M, et al
   Adult-onset type 1 diabetes: early detection, differential diagnosis, and emerging disease-modifying therapies.
   Diabetes Res Clin Pract. 2026;231:113047.
   PubMed         Abstract available
   
   
5. PAVAN J, Nass R, Fabris C, Fathi AE, et al
   Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trial.
   Diabetes Res Clin Pract. 2026;231:113049.
   PubMed         Abstract available
   
   
6. PASSANISI S, Piona C, Mancioppi V, Puli L, et al
   Optimal age, duration of diabetes and frequency of screening for diabetic nephropathy in children and youths with type 1 Diabetes: A systematic review.
   Diabetes Res Clin Pract. 2026;231:113042.
   PubMed         Abstract available
   
   
7. SOTIRIOU G, Dimitriadou M, Nemtsa A, Kavoura E, et al
   When the summer camp ends: Short-term, post-camp deterioration of glycemic control in youth with type 1 diabetes.
   Diabetes Res Clin Pract. 2026;231:113039.
   PubMed         Abstract available
   
   
8. QIN L, Ma W, Cui S, Du Y, et al
   Global burden of type 1 diabetes in adults aged 40-64: trends from 1990 to 2021 and projections to 2036.
   Diabetes Res Clin Pract. 2026;231:113022.
   PubMed         Abstract available
   
   
9. GONCALVES S, Coelho C, Pretre L, Roussillon C, et al
   Chat, Gemini and Claude at the dinner table: assessing general-purpose AI tools for carbohydrate counting in the context of type 1 diabetes.
   Diabetes Res Clin Pract. 2026;231:113031.
   PubMed         Abstract available
   
   
10. LLAURADO G, Cano A, Gimenez-Palop O, Albert L, et al
    Insulin resistance and abdominal adiposity discriminate early vascular aging (higher vascular risk) in adults with type 1 diabetes without cardiovascular events.
    Diabetes Res Clin Pract. 2026;231:113010.
    PubMed         Abstract available
    
    

    
    J Neurol

11. GYGER N, Monschein T, Filser M, Batge S, et al
    Cognitive training, exercise training or combined training? A comparative effectiveness research study on subjective and objective cognitive outcomes in multiple sclerosis.
    J Neurol. 2026;273:82.
    PubMed         Abstract available
    
    
12. GRECO G, Della Porta G, Masi F, Redemagni C, et al
    Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments.
    J Neurol. 2026;273:77.
    PubMed         Abstract available
    
    

    
    N Engl J Med

13. LI R, Pan H, Zhang L, Ma J, et al
    CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.
    N Engl J Med. 2026;394:253-267.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.